2021
DOI: 10.1186/s12944-021-01510-z
|View full text |Cite
|
Sign up to set email alerts
|

Adiponectin in psoriasis and its comorbidities: a review

Abstract: Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by abnormal T cell activation and excessive proliferation of keratinocytes. In addition to skin manifestations, psoriasis has been associated with multiple metabolic comorbidities, such as obesity, insulin resistance, and diabetes. An increasing amount of evidence has highlighted the core role of adipokines in adipose tissue and the immune system. This review focus on the role of adiponectin in the pathophysiology of psoriasis and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 142 publications
(160 reference statements)
1
9
0
Order By: Relevance
“…Noteworthy, dissimilar to the above mentioned autoim mune conditions, adiponectin can act on keratinocytes and naïve Tcells and therefore has its rather an antiinflamma tory role in the pathogenesis of one more autoimmune dis order psoriasis by increasing the production of IL10, while inhibiting the production and activity of IL2, Il6, IL8, IL17, IL22, TNFα and IFNγ [162]. Moreover, adiponectin similar ly to adipocytes is expressed in human sebaceous glands affecting the homeostasis of the dermis.…”
Section: Adiponectin and Various Diseasesmentioning
confidence: 99%
See 1 more Smart Citation
“…Noteworthy, dissimilar to the above mentioned autoim mune conditions, adiponectin can act on keratinocytes and naïve Tcells and therefore has its rather an antiinflamma tory role in the pathogenesis of one more autoimmune dis order psoriasis by increasing the production of IL10, while inhibiting the production and activity of IL2, Il6, IL8, IL17, IL22, TNFα and IFNγ [162]. Moreover, adiponectin similar ly to adipocytes is expressed in human sebaceous glands affecting the homeostasis of the dermis.…”
Section: Adiponectin and Various Diseasesmentioning
confidence: 99%
“…Patients with pso riasis have lower plasma adiponectin levels which thereby may lead to increased production of proinflammatory cy tokines and lack of antiinflammatory ones which eventual ly worsen the severity of their skin lesions. In keratinocytes the decrease in adiponectin levels has been shown to result in the reduced E2F1 gene activation through AMPK pathway promoting the proliferation of keratinocytes and inducing abnormal cell apoptosis thus interacting with the infiltration of the inflammatory response and leading to psoriasis [162].…”
Section: Adiponectin and Various Diseasesmentioning
confidence: 99%
“…Psoriasis as a chronic systemic inflammatory disease that shares pro-inflammatory mechanisms with obesity, including Th1 cytokines [interferon-γ, interleukin (IL)-2, IL-12, and tumor necrosis factor (TNF)-α] ( 35 ). More recently, the family of adipokines have been involved in the obesity-driven inflammation in psoriasis ( 36 ). Obesity is an independent risk factor associated with psoriasis severity and response to systemic therapy (i.e., methotrexate, cyclosporine, apremilast, and biologic agents) ( 37 39 ).…”
Section: Chronic Skin Conditions Influenced By Comorbid Obesitymentioning
confidence: 99%
“…Adiponectin plays a crucial role in controlling psoriasiform dermatosis by reducing Th17 cell differentiation, restraining glycolysis in an AMPK dependent fashion, thus tightly regulating their nutritional demands and metabolic function [91][92][93]. Psoriasis patients with or without metabolic abnormalities exhibit significant hypoadiponectinemia (negatively corelated with psoriasis area severity index, PASI) and hyperleptinemia with leptin resistance (positively corelated with PASI), that contribute to the development of the metabolic syndrome.…”
Section: Obesity Systemic Immunometabolism and Psoriasismentioning
confidence: 99%